Isomorphic Labs Chief Executive Officer Demis Hassabis stated that the $5 billion in new capital will accelerate the company's platform scale toward designing hundreds of drugs annually and moving into clinical trials
Agree
Disagree
Overview
Debates
Related claims
Topics
Sources
4
41e85161
Topic
AI startups
1,567
claims
·
751
news stories
0
4
41e85161
Topic
AI Capital Surge
378
claims
·
174
news stories
0
Opening sign-in…